CPAP reduces mortality and cardiovascular risk in OSA

A major scientific breakthrough has just reinforces the importance of sleep apnea treatment! On March 18th, 2025, The Lancet Respiratory Medicine published a meta-analysis. It confirms, with high certainty, that CPAP reduces the risk of death from all causes. This includes cardiovascular-related deaths.

This study analyzed randomized controlled trials and observational studies. These were adjusted for confounding factors. The results show that CPAP treatment does more than just improve sleep quality. It also plays a crucial role in protecting against severe complications, particularly cardiovascular diseases.

In practical terms for you:

  • People with Obstructive Sleep Apnea (OSA) who use CPAP have a 37% lower risk of death from all causes.
  • The treatment reduces the risk of severe cardiovascular complications by 55%.
  • Regular follow-ups and good adherence to treatment are essential to maximize these benefits.

We are here to support you in your treatment and optimize your comfort with the CPAP. If you have any questions or need adjustments to your equipment, please do not hesitate to contact us.

Take care of your sleep, take care of your health.

The ClinicTCO team

Leave a Reply

Your email address will not be published. Required fields are marked *